Cord Blood Clinical Trials

3 recruiting

Cord Blood Trials at a Glance

10 actively recruiting trials for cord blood are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Hefei, Milan, and Houston. Lead sponsors running cord blood studies include Anhui Provincial Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico.

Browse cord blood trials by phase

Treatments under study

About Cord Blood Clinical Trials

Looking for clinical trials for Cord Blood? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cord Blood trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cord Blood clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia

General AnesthesiaSpinal AnesthesiaCesarean Section Surgery+2 more
Sisli Hamidiye Etfal Training and Research Hospital100 enrolled1 locationNCT07321041
Recruiting

Double Unit Cord Blood Transplant in Hematologic Malignancies.

Adult Double Unit Cord Blood Transplant
Seoul National University Hospital40 enrolled6 locationsNCT06712108
Recruiting
Phase 2

Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders

Epstein-Barr Virus-associated Lymphoproliferative DiseasesChronic Active Epstein-Barr Virus InfectionEBV Associated Lymphoma+1 more
Fudan University80 enrolled2 locationsNCT07381738
Recruiting
Not Applicable

Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study

Cord BloodPeyronie DiseasePenile Curvature+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico42 enrolled1 locationNCT07010900
Recruiting

Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)

Hematological MalignanciesCord Blood Transplantation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10 enrolled1 locationNCT03802773
Recruiting

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital40 enrolled1 locationNCT05823376
Recruiting
Phase 2

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital34 enrolled1 locationNCT06693791
Recruiting
Phase 3

Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients

Acute T Cell Lymphoblastic LeukemiaHaploidentical Hematopoietic Stem Cell TransplantationCord Blood
The First Affiliated Hospital of Soochow University146 enrolled1 locationNCT06381817
Recruiting
Not Applicable

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

LeukemiaCord BloodStem Cell Transplant
Nanfang Hospital, Southern Medical University60 enrolled1 locationNCT06155188
Recruiting

The Collection and Storage of Umbilical Cord Blood for Transplantation

Hematopoietic Stem Cell TransplantationCord Blood TransplantationCord Blood Stem Cell Transplantation
M.D. Anderson Cancer Center250,000 enrolled1 locationNCT01728545